Solvay Wants Firms, Expert Removed In AndroGel Suit
Law360 (March 24, 2011, 6:05 PM EDT) -- Solvay Pharmaceuticals Inc. and two other drugmakers on Tuesday sought to disqualify an expert witness and two law firms from multidistrict litigation in Georgia over whether the companies' AndroGel patent settlements violated antitrust law.
Solvay says that Dr. Howard Maibach, who served as its consultant in the underlying patent litigation over the hormone drug, shared confidential information from that suit with the law firms of Heim Payne & Chorush LLP and Garwin Gerstein & Fisher LLP, according to a memorandum of law filed in the U.S. District Court for the Northern District of Georgia.
The retention of Dr. Maibach “has thus...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!